HI
COLL icon

Horizon Investments’s Collegium Pharmaceutical COLL Stock Holding History

Horizon Investments’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$628K Buy
18,980
+6,050
+47% +$256K 0.01% 851
2025
Q4 		$599K Sell
12,930
-1,698
-12% -$71K 0.01% 817
2025
Q3 		$512K Buy
+14,628
New +$508K 0.01% 835

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Horizon Investments's COLL Position: Q1 2026 in Review

Horizon Investments increased its Collegium Pharmaceutical (COLL) stake by 47% in Q1 2026, buying an estimated $256K and bringing the position to 18,980 shares worth $628K. The position accounts for 0.01% of the portfolio, ranked #851.

Horizon Investments first reported a position in COLL in Q3 2025 and has held it in 3 quarters since. 267 funds tracked by Wall St. Rank hold COLL as of Q1 2026.

  • Horizon Investments held 18,980 shares of Collegium Pharmaceutical worth $628K as of Q1 2026.
  • Horizon Investments bought 6,050 Collegium Pharmaceutical shares in Q1 2026, an estimated $256K.
  • Collegium Pharmaceutical made up 0.01% of Horizon Investments's portfolio in Q1 2026, its #851 holding.
  • Horizon Investments first reported a position in Collegium Pharmaceutical in Q3 2025 and has held it in 3 quarters since.
  • 267 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2026.

Based on Horizon Investments's 13F filing for Q1 2026, filed 15 May 2026.